OAM
ACHN
Oxford Asset Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-601,375
| Closed | -$2.17M | – | 2256 |
|
2019
Q3 | $2.17M | Sell |
601,375
-360,564
| -37% | -$1.3M | 0.05% | 489 |
|
2019
Q2 | $2.58M | Buy |
961,939
+11,470
| +1% | +$30.7K | 0.06% | 527 |
|
2019
Q1 | $2.81M | Sell |
950,469
-364,208
| -28% | -$1.08M | 0.06% | 419 |
|
2018
Q4 | $2.09M | Buy |
1,314,677
+710,639
| +118% | +$1.13M | 0.05% | 445 |
|
2018
Q3 | $2.22M | Buy |
604,038
+336,376
| +126% | +$1.24M | 0.05% | 607 |
|
2018
Q2 | $761K | Buy |
267,662
+48,673
| +22% | +$138K | 0.01% | 1165 |
|
2018
Q1 | $812K | Sell |
218,989
-143,633
| -40% | -$533K | 0.02% | 1030 |
|
2017
Q4 | $1.07M | Buy |
362,622
+335,529
| +1,238% | +$990K | 0.02% | 899 |
|
2017
Q3 | $121K | Sell |
27,093
-64,691
| -70% | -$289K | ﹤0.01% | 1468 |
|
2017
Q2 | $421K | Buy |
+91,784
| New | +$421K | 0.01% | 1163 |
|
2017
Q1 | – | Sell |
-210,165
| Closed | -$868K | – | 1523 |
|
2016
Q4 | $868K | Sell |
210,165
-595,802
| -74% | -$2.46M | 0.03% | 499 |
|
2016
Q3 | $6.53M | Buy |
+805,967
| New | +$6.53M | 0.2% | 118 |
|
2016
Q2 | – | Sell |
-608,481
| Closed | -$4.7M | – | 922 |
|
2016
Q1 | $4.7M | Sell |
608,481
-240,698
| -28% | -$1.86M | 0.13% | 174 |
|
2015
Q4 | $9.17M | Buy |
849,179
+25,990
| +3% | +$281K | 0.22% | 85 |
|
2015
Q3 | $5.69M | Buy |
823,189
+412,812
| +101% | +$2.85M | 0.18% | 105 |
|
2015
Q2 | $3.64M | Sell |
410,377
-214,702
| -34% | -$1.9M | 0.1% | 228 |
|
2015
Q1 | $6.16M | Buy |
625,079
+190,626
| +44% | +$1.88M | 0.16% | 154 |
|
2014
Q4 | $5.33M | Buy |
434,453
+254,945
| +142% | +$3.13M | 0.12% | 189 |
|
2014
Q3 | $1.81M | Buy |
+179,508
| New | +$1.81M | 0.04% | 390 |
|
2013
Q3 | – | Sell |
-504,861
| Closed | -$4.13M | – | 962 |
|
2013
Q2 | $4.13M | Buy |
+504,861
| New | +$4.13M | 0.11% | 301 |
|